Report Update Nov 1, 2024

Indonesia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Indonesia: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Indonesia

In 2021, after four years of growth, there was decline in the Indonesian medicaments containing insulin market, when its value decreased by -4.1% to $X. Overall, consumption, however, continues to indicate a abrupt descent. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Indonesia

In value terms, medicaments containing insulin production shrank to $X in 2021 estimated in export price. Over the period under review, the total production indicated perceptible growth from 2012 to 2021: its value increased at an average annual rate of +2.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +56.8% against 2015 indices. The pace of growth was the most pronounced in 2020 with an increase of 11%. As a result, production attained the peak level of $X, and then fell in the following year.

Medicaments Containing Insulin Exports

Exports from Indonesia

In 2021, shipments abroad of medicaments containing insulin but not antibiotics decreased by -50% to X kg, falling for the seventh year in a row after three years of growth. Over the period under review, exports showed a dramatic decrease. The pace of growth was the most pronounced in 2014 with an increase of 189% against the previous year. As a result, the exports reached the peak of X kg. From 2015 to 2021, the growth of the exports failed to regain momentum.

In value terms, medicaments containing insulin exports contracted remarkably to $X in 2021. In general, exports saw a dramatic descent. The most prominent rate of growth was recorded in 2014 when exports increased by 156% against the previous year. As a result, the exports reached the peak of $X. From 2015 to 2021, the growth of the exports failed to regain momentum.

Exports by Country

Timor-Leste (X kg) was the main destination for medicaments containing insulin exports from Indonesia, with a approx. 90% share of total exports.

From 2012 to 2021, the average annual growth rate of volume to Timor-Leste totaled -26.2%.

In value terms, Timor-Leste ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics exports from Indonesia.

From 2012 to 2021, the average annual rate of growth in terms of value to Timor-Leste amounted to -23.9%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, with an increase of 28% against the previous year. Overall, export price indicated prominent growth from 2012 to 2021: its price increased at an average annual rate of +5.3% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing insulin export price increased by +124.1% against 2015 indices. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

As there is only one major export destination, the average price level is determined by prices for Timor-Leste.

From 2012 to 2021, the rate of growth in terms of prices for Timor-Leste amounted to +2.6% per year.

Medicaments Containing Insulin Imports

Imports into Indonesia

In 2021, medicaments containing insulin imports into Indonesia declined markedly to X kg, dropping by -22.6% on 2020. In general, imports showed a significant contraction. The smallest decline of -11.1% was in 2018. Imports peaked at X tons in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports shrank notably to $X in 2021. Overall, imports showed a precipitous decrease. The smallest decline of -11.9% was in 2018. Over the period under review, imports attained the peak figure at $X in 2012; however, from 2013 to 2021, imports failed to regain momentum.

Imports by Country

China (X kg) and Malaysia (X kg) were the main suppliers of medicaments containing insulin imports to Indonesia.

From 2013 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Malaysia (with a CAGR of 0.0%).

In value terms, China ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Indonesia, comprising 99% of total imports. The second position in the ranking was held by Malaysia ($X), with a 0.8% share of total imports.

From 2013 to 2021, the average annual rate of growth in terms of value from China amounted to -14.2%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, standing approx. at the previous year. Over the last eight-year period, it increased at an average annual rate of +2.4%. The pace of growth was the most pronounced in 2016 an increase of 10%. As a result, import price reached the peak level of $X per ton. From 2017 to 2021, the average import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, amid the top importers, the country with the highest price was China ($X per ton), while the price for Malaysia totaled $X per ton.

From 2013 to 2021, the most notable rate of growth in terms of prices was attained by China (+9.4%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin consumption was Denmark, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. Pakistan ranked third in terms of total consumption with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to Indonesia?

In value terms, the largest medicaments containing insulin suppliers to Indonesia were Singapore, the U.S. and Japan.

What are the leading importers of medicaments containing insulin but not antibiotics from Indonesia?

In value terms, Timor-Leste remains the key foreign market for medicaments containing insulin exports from Indonesia.

What is the average export price for medicaments containing insulin but not antibiotics in Indonesia?

The average medicaments containing insulin export price stood at $1,011 per ton in 2020, declining by -20% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Indonesia?

In 2020, the average medicaments containing insulin import price amounted to $184,592 per ton, rising by 7.9% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Indonesia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Indonesia

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Indonesia
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023